Clinical Trials Browser

Interventional × Solid Neoplasm × Bevacizumab × Clear all

NCT01749384 2017-10-12

Tivantinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Phase 1 Completed

Solid Neoplasm